Clinical Trials Browser

Lymphoma, Large B-Cell, Diffuse

Prostatic Neoplasms

Adrenal Insufficiency, Myasthenia Gravis

Lymphoma, Large B-Cell, Diffuse

Prostatic Neoplasms

Lymphoma, Follicular, Recurrence

Ovarian Neoplasms

Biliary Tract Neoplasms, Ovarian Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung, Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms, Triple Negative Breast Neoplasms

Lymphoma, Follicular

Prostatic Neoplasms

Hodgkin Disease

Lymphoma, Large B-Cell, Diffuse

Lymphoma, B-Cell

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Prostatic Neoplasms, Bulbo-Spinal Atrophy, X-Linked

Metastatic Castration-resistant Prostate Cancer

Prostatic Neoplasms

Lymphoma, Follicular

Lymphoma, Large B-Cell, Diffuse

Neoplasm Metastasis, Prostatic Neoplasms, Urogenital Neoplasms

Metastatic Castration-resistant Prostate Cancer

Prostatic Neoplasms

Parkinson Disease 4, Autosomal Dominant Lewy Body, Prostatic Neoplasms

Neoplasm Metastasis, Prostatic Neoplasms

Prostatic Neoplasms

Multiple Myeloma

Metastatic Castration-Resistant Prostate Cancer

Prostatic Neoplasms

Metastatic Castration-Resistant Prostate Cancer Patients

Prostatic Neoplasms

Lymphoma, Follicular, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse

Prostatic Neoplasms

Prostatic Neoplasms

Prostatic Neoplasms

Lymphoma, Lymphoma, Large B-Cell, Diffuse, Dendritic Cell Sarcoma, Interdigitating

Lymphoma, Non-Hodgkin

Breast Neoplasms, Stomatitis, Oral Ulcer

Lymphoma, Large B-Cell, Diffuse

Advanced Cancer

Lymphoma, Follicular

Breast Neoplasms, Neoplasm Metastasis

Lymphoma, Follicular

Prostatic Neoplasms

Lymphoma, Non-Hodgkin

Prostatic Neoplasms

Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse

Lymphoma, Follicular

Prostatic Neoplasms

Clinical Trials

MK-2140-010

MK-2400-001

OCTAGON

MK-2140-011

A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer

LEDA

M9466 Alone or in Combination in Advanced Solid Tumors (DDriver 501)

Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)

A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types

OLYMPIA-1

EvoPAR-PR02

MK-3475-667

OLYMPIA-3

Study of Safety and Efficacy of Iberdomide (CC-220) and CC-99282 Combined With R-CHOP to Treat Lymphoma

Safety and Efficacy of Asciminib in Pediatrics and Young Adults With Relapse/Refractory (r/r) Philadelphia Positive (Ph+) or ABL-class Ph-like Acute Lymphoblastic Leukemia (ALL)

rechARge

A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer

A Registry Study to Observe Clinical Outcomes of Participants With High-risk Metastatic Hormone-naïve Prostate Cancer in Japan

A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4)

A Phase I/II Study of TRS005 in Combination With Cyclophosphamide, Doxorubicin, and Prednisone（T-CHP） in Previously Untreated Patients With CD20-positive DLBCL

CYCLONE 3

Pre-approval Access Single Patient Request for Niraparib / Abiraterone Acetate Combination (Nira/AA Combination)

IPATential150

KEYLYNK-010

PRESIDE

ERA 223

VCAT

A Study of Abiraterone Acetate in Metastatic Castration-Resistant Prostate Cancer Participants Who Responded Poorly to the First-line Combined Androgen Blockade Therapy

A Study of EPI-7386 in Combination With Abiraterone Acetate Plus Prednisone, or Apalutamide in Metastatic Castration-resistant Prostate Cancer (mCRPC)

Irofulven in AR-targeted and Docetaxel-Pretreated mCRPC Patients With Drug Response Predictor (DRP®)

waveLINE-007

A Study of HSP90 Inhibitor AT13387 Alone or in Combination With Abiraterone Acetate

Study of Tazemetostat as Single Agent in Solid Tumors or B-cell Lymphomas and in Combination With Prednisolone in DLBCL

Ph II Study to Evaluate Olaparib With Abiraterone in Treating Metastatic Castration Resistant Prostate Cancer.

PLATO

Study of Ipatasertib or Apitolisib With Abiraterone Acetate Versus Abiraterone Acetate in Participants With Castration-Resistant Prostate Cancer Previously Treated With Docetaxel Chemotherapy

A Study of Durvalumab in Combination With R-CHOP or Lenalidomide Plus R-CHOP in Previously Untreated High-Risk Diffuse Large B-Cell Lymphoma

A Study of Polatuzumab Vedotin in Combination With Rituximab or Obinutuzumab, Cyclophosphamide, Doxorubicin, and Prednisone in Participants With B-Cell Non-Hodgkin's Lymphoma

Miracle Mouthwash Plus Hydrocortisone vs Prednisolone Mouth Rinse for Mouth Sores Caused by Everolimus

First-line Treatment of P53 Mutation With PD-L1 Expression in DLBCL With Anti-PD-1 Mab and R-CHOP

A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Therapies in Japanese Participants With Advanced Cancer

rituximab

A Study of Abiraterone Acetate Plus Prednisone With or Without Exemestane in Postmenopausal Women With Estrogen Receptor-Positive (ER+) Metastatic Breast Cancer Progressing After Letrozole or Anastrozole Therapy

Study of MK-8808 for Participants With Follicular Lymphoma (MK-8808-001)

A Study of Abiraterone Acetate (JNJ-212082) and Prednisolone in Patients With Advanced Prostate Cancer

A Study of Rituximab (MabThera) Subcutaneous (SC) Versus Rituximab (MabThera) Intravenous in Participannts With Follicular Non-Hodgkin's Lymphoma

A Study of Abiraterone Acetate Plus Prednisone in Asymptomatic or Mildly Symptomatic Patients With Metastatic Castration-Resistant Prostate Cancer

A Study of Participant Preference With Subcutaneous Versus Intravenous MabThera/Rituxan in Participants With CD20+ Diffuse Large B-Cell Lymphoma or CD20+ Follicular Non-Hodgkin's Lymphoma Grades 1, 2 or 3a

Study Comparing Inotuzumab Ozogamicin In Combination With Rituximab Versus Defined Investigator's Choice In Follicular Non-Hodgkin's Lymphoma (NHL)

A Phase 2 Study to Evaluate Safety and Efficacy of Abiraterone in Participants With Prostate Cancer